APOLLO REVOLUTIONIZES PROSTATE CANCER SCREENING FOR INDIAN MEN WITH GROUNDBREAKING STUDY.

In a monumental stride towards advancing prostate cancer in India,Apollo Hospitals,the world's largest integrated health care provider,has unveiled ground breaking findings in its latest study,'Determining age-specific prostate -specific antigen for healthy Indian men" published in the prestigeous Indian Journal of urology led by DR.N,Raghavan and Dr.Sanjai Addla,from Apollo Chennai and Apollo,Hyderabad respectively.Thee study involved nearly 1,00,000 healthy men across diverse age groups and regions in India establishing new reference values for prostate specific antigen (PSA)specific to the Indian demographic.

        PSA is an established blood marker for early diagnosis and monitoring of treatment  for prostate cancer .Since 1993,International norms for normal PSA values have been based on a study from the USA and the same have been adopted in India.The western standards quiet often were found to be ill suited for the Indian population over to diverse genetic demarcations.This latest groundbreaking Apollo study reveals that PSA values in India differ,prompting the establishment of new tailored standards.Key findings include age specific  PSA standards,a progressive increase in PSA levels with age,and Indian specific PSA values facilitating earlier detection in younger men. 

Dr.Sangita Reddy,Joint Managing Director,Apollo Hospitals, said,"This landmark study ushers a transformative moment in India's prostate cancer care landscape,which resonates with our mission to conquer cancer at every touchpoint possible".